PAMAM conjugated chitosan through naphthalimide moiety for enhanced gene transfection efficiency

Carbohydrate Polymers

Volumn 98, Issue 1, 2013, Pages 495-504

  Sarkar, Kishor ^a   Kundu, P P ^a  

^a UNIVERSITY OF CALCUTTA   (India)

Author keywords

Chitosan; Cytotoxicity; In vitro; PAMAM dendrimer; Transfection

Indexed keywords

BLOOD; CYTOTOXICITY; EFFICIENCY; GENE THERAPY; GENE TRANSFER; SUBSTITUTION REACTIONS;

BLOOD COMPATIBILITY; GENE DELIVERY VECTORS; IN-VITRO; PAMAM DENDRIMER; POLYETHYLENEIMINE; TRANSFECTION; TRANSFECTION EFFICIENCY; WATER SOLUBILITIES;

CHITOSAN;

BIOMATERIAL; BUFFER; CHITOSAN; DENDRIMER; DEOXYRIBONUCLEASE I; DNA; DRUG CARRIER; NAPHTHALIMIDE DERIVATIVE; PAMAM STARBURST;

ARTICLE; CHEMISTRY; CYTOTOXICITY; GENETIC TRANSFECTION; GENETICS; HELA CELL; HUMAN; IN VITRO STUDY; METABOLISM; METHODOLOGY; PAMAM DENDRIMER; PARTICLE SIZE;

CHITOSAN; CYTOTOXICITY; IN VITRO; PAMAM DENDRIMER; TRANSFECTION;

BIOCOMPATIBLE MATERIALS; BUFFERS; CHITOSAN; DENDRIMERS; DEOXYRIBONUCLEASE I; DNA; DRUG CARRIERS; HELA CELLS; HUMANS; NAPHTHALIMIDES; PARTICLE SIZE; TRANSFECTION;

EID: 84885118255     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbpol.2013.06.006     Document Type: Article

References (50)

1. Benjaminsen, R. V., Mattebjerg, M. A., Henriksen, J. R., Moghimi, S. M., & Andresen, T. L. (2013). The possible "proton sponge" effect of polyethylenimine (PEI) does not include change in lysosomal pH. Molecular Therapy, 21, 149-157.
2. Cross, D., & Burmester, J. K. (2006). Gene therapy for cancer treatment: Past, present and future. Clinical Medicine & Research, 4, 218-227. (Pubitemid 44496015)
3. Daya, S., & Berns, K. I. (2008). Gene therapy using adeno-associated virus vectors. Clinical Microbiology Reviews, 21, 583-593.
4. Denyer, R., & Douglas, M. R. (2012). Gene therapy for Parkinson's disease. Parkinson's Disease, 2012, 1-13.
5. Dishart, K. L., Work, L. M., Denby, L., & Baker, A. H. (2003). Gene therapy for cardiovascular disease. Journal of Biomedicine and Biotechnology, 21, 138-148. (Pubitemid 36828266)
6. Dufes, C., Uchegbu, I. F., & Schatzlein, A. G. (2005). Dendrimers in gene delivery. Advanced Drug Delivery Reviews, 57, 2177-2202. (Pubitemid 41759392)
7. He, C. X., Tabata, Y., & Gao, J. Q. (2010). Non-viral gene delivery carrier and its three dimensional transfection system. International Journal of Pharmaceutics, 386, 232-242.
8. Huang, M., Fong, C. W., Khor, E., & Lim, L. Y. (2005). Transfection efficiency of chitosan vectors: Effect of polymer molecular weight and degree of deacetylation. Journal of Controlled Release, 106, 391-406. (Pubitemid 41187448)
9. Hunter, A. C., & Moghimi, S. M. (2010). Cationic carriers of genetic material and cell death: A mitochondrial tale. Biochimica et Biophysica Acta, 1797, 1203-1209.
10. Jia, W., & Zhou, Q. (2005). Viral vectors for cancer gene therapy: Viral dissemination and tumor targeting. Current Gene Therapy, 5, 133-142. (Pubitemid 40246746)
11. Jiang, X., Dai, H., Leong, K. W., Goh, S. H., Mao, H. Q., & Yang, Y. Y. (2006). Chitosan-g- PEG/DNA complexes deliver gene to the rat liver via intrabiliary and intraportal infusions. Journal of Gene Medicine, 8, 477-487.
12. Jewell, C. M., & Lynn, D. M. (2008). Surface-mediated delivery of DNA: Cationic polymers take charge. Current Opinion in Colloid & Interface Science, 13, 395-402.
13. Kean, T., Roth, S., & Thanou, M. (2005). Trimethylated chitosans as non-viral gene delivery vectors: Cytotoxicity and transfection efficiency. Journal of Controlled Release, 103, 643-653. (Pubitemid 40471022)
14. Kundu, P. P., & Sarkar, K. (2011). Natural polymeric vectors in gene therapy. In S. Kalia, & L. Avérous (Eds.), Biopolymers: Biomedical and Environmental application (pp. 575-604). New Jersey: John Wiley & Sons Inc.
15. Lechardeur, D., & Lukacs, G. L. (2002). Intracellular barriers to non-viral gene transfer. Current Gene Therapy, 2, 183-194.
16. Li, S. D., & Huang, L. (2006). Gene therapy progress and prospects: Non-viral gene therapy by systemic delivery. Gene Therapy, 13, 1313-1319. (Pubitemid 44323687)
17. Lu, B., Sun, Y. X., Li, Y., Zhang, Q., & Zhuo, X. Z. R. X. (2009). N-succinyl-chitosan grafted with low molecular weight polyethylenimine as a serum-resistant gene vector. Molecular BioSystems, 5, 629-637.
18. Lu, B., Wang, C. F., Wu, D. Q., Li, C., Zhang, X. Z., & Zhuo, R. X. (2009). Chitosan based oligoamine polymers: Synthesis, characterization, and gene delivery. Journal of Controlled Release, 137, 54-62.
19. Lu, B., Xu, X. D., Zhang, X. Z., Cheng, S. X., & Zhuo, R. X. (2008). Low molecular weight polyethylenimine grafted N-maleated chitosan for gene delivery: Properties and in vitro transfection studies. Biomacromolecules, 9, 2594-2600.
20. Lungwitz, U., Breunig, M., Blunk, T., & Göpferich, A. (2005). Polyethylenimine-based non-viral gene delivery systems. European Journal of Pharmaceutics and Biopharmaceutics, 60, 247-266. (Pubitemid 40804565)
21. Merdan, T., Kopecek, J., & Kissel, T. (2002). Prospects for cationic polymers in gene and oligonucleotide therapy against cancer. Advanced Drug Delivery Reviews, 54, 715-758. (Pubitemid 35247524)
22. Miller, A. D. (1998). Cationic liposomes for gene therapy. Angewandte Chemie International Edition, 37, 1768-1785.
23. Moghimi, S. M., Symonds, P., Murray, J. C., Hunter, A. C., Debska, G., & Szewczyk, A. (2005). A two-stage poly(ethylenimine)-mediated cytotoxicity: Implications for gene transfer/therapy. Molecular Therapy, 11, 990-995. (Pubitemid 40724119)
24. Morille, M., Passirani, C., Vonarbourg, A., Clavreul, A., & Benoit, J. P. (2008). Progress in developing cationic vectors for non-viral systemic gene therapy against cancer. Biomaterials, 29, 3477-3496.
25. Mukherjee, S., Davoren, M., & Byrne, H. (2010). In vitro mammalian cytotoxicological study of PAMAM dendrimers - Towards quantitative structure activity relationships. Toxicology In Vitro, 24, 169-177.
26. Muzzarelli, R. A. A. (2010a). Chitosans: New vectors for gene therapy. In R. Ito, & Y. Matsuo (Eds.), Handbook of carbohydrate polymers: Development, properties and applications (pp. 583-604). Hauppauge, NY, USA: Nova Publ.
27. Muzzarelli, R. A. A. (2010b). Chitins and chitosans as immunoadjuvants and nonallergenic drug carriers. Marine Drugs, 8, 292-312.
28. Nilsson, P., Iwata, N., Muramatsu, S., Tjernberg, L. O., Winblad, B., & Saido, T. C. (2010). Gene therapy in Alzheimer's disease potential for disease modification. Journal of Cellular and Molecular Medicine, 14, 741-757.
29. Niidome, T., & Huang, L. (2002). Gene therapy progress and prospects: Nonviral vectors. Gene Therapy, 9, 1647-1652. (Pubitemid 36104607)
30. Pedroso de Lima, M. C., Neves, S., Filipe, A., Düzgüneş , N., & Simões, S. (2003). Cationic liposomes for gene delivery: From biophysics to biological applications. Current Medicinal Chemistry, 10, 1221-1231. (Pubitemid 36763932)
31. Pérez-Martínez, F. C., Guerra, J., Posadas, I., & Ceña, V. (2011). Barriers to non-viral vector-mediated gene delivery in the nervous system. Pharmaceutical Research, 28, 1843-1858.
32. Romano, G. (2007). Development of safer gene delivery systems to minimize the risk of insertional mutagenesis-related malignancies: A critical issue for the field of gene therapy. Drug News & Perspectives, 20, 227-231.
33. Sadekar, S., & Ghandehari, H. (2012). Transepithelial transport and toxicity of PAMAM dendrimers: Implications for oral drug delivery. Advanced Drug Delivery Reviews, 64, 571-588.
34. Samal, S. K., Dash, M., Vlierberghe, S. V., Kaplan, D. L., Chiellini, E., van Blitterswijk, C., et al. (2012). Cationic polymers and their therapeutic potential. Chemical Society Reviews, 41, 7147-7194.
35. Sarkar, K., & Kundu, P. P. (2012). Preparation of low molecular weight N-maleated chitosan-graft-PAMAM copolymer for enhanced DNA complexation. International Journal of Biological Macromolecules, 51, 859-867.
36. Sarkar, K., Debnath, M., & Kundu, P. P. (2012). Recyclable crosslinked Ocarboxymethyl chitosan for removal of cationic dye from aqueous solutions. Hydrology Current Research, 3, 1-9.
37. Sarkar, K., Debnath, M., & Kundu, P. P. (2013). Preparation of low toxic fluorescent chitosan-graft-polyethyleneimine copolymer for gene carrier. Carbohydrate Polymers, 92, 2048-2057.
38. Sarkar, K., Srivastava, R., Chatterji, U., & Kundu, P. P. (2011). Evaluation of chitosan and their self-assembled nanoparticles with pDNA for the application in gene therapy. Journal of Applied Polymer Science, 121, 2239-2249.
39. Shi, B., Shen, Z., Zhang, H., Bi, J., & Dai, S. (2012). Exploring N-imidazolyl-Ocarboxymethyl chitosan for high performance gene delivery. Biomacromolecules, 13, 146-153.
40. Simões, S., Filipe, A., Faneca, H., Mano, M., Penacho, N., Düzgünes, N., et al. (2005). Cationic liposomes for gene delivery. Expert Opinion on Drug Delivery, 2, 237-254. (Pubitemid 41135785)
41. Stone, D., David, A., Bolognani, F., Lowenstein, P. R., & Castro, M. G. (2000). Viral vectors for gene delivery and gene therapy within the endocrine system. Journal of Endocrinology, 164, 103-118. (Pubitemid 30114658)
42. Sun, J. Y., Chatterjee, S., & Wong, K. K., Jr. (2002). Immunogenic issues concerning recombinant adeno-associated virus vectors for gene therapy. Current Gene Therapy, 2, 485-500.
43. Svenson, S., & Tomalia, D. A. (2005). Dendrimers in biomedical applications. Advanced Drug Delivery Reviews, 57, 2106-2129.
44. Thanou, M., Florea, B. I., Geldof, M., Junginger, H. E., & Borchard, G. (2002). Quaternized chitosan oligomers as novel gene delivery vectors in epithelial cell lines. Biomaterials, 23, 153-159. (Pubitemid 33041349)
45. Thomas, C. E., Ehrhardt, A., & Kay, M. A. (2003). Progress and problems with the use of viral vectors for gene therapy. Nature Reviews Genetics, 4, 346-358. (Pubitemid 36538359)
46. Tomalia, D. A., & Frechet, J. M. (2005). Introduction to dendrimers and dendritic polymers. Progress in Polymer Science, 30, 217-219.
47. Waehler, R., Russell, S. J., & Curiel, D. T. (2007). Engineering targeted viral vectors for gene therapy. Nature Reviews Genetics, 8, 573-587. (Pubitemid 47077278)
48. Walther, W., & Stein, U. (2000). Viral vectors for gene transfer. Drugs, 60, 249-271.
49. Wightman, L., Kircheis, R., Rössler, V., Carotta, S., Ruzicka, R., Kursa, M., et al. (2001). Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo. Journal of Gene Medicine, 3, 362-372. (Pubitemid 33691776)
50. Zhou, H., Liu, D., & Liang, C. (2004). Challenges and strategies: The immune responses in gene therapy. Medicinal Research Reviews, 24, 748-761. (Pubitemid 39362482)